Biotech Business - September 20, 2023
Evaxion enters partnership with Afrigen Biologics
The two collaborators aim to develop a prophylactic vaccine based on Evaxion’s EDEN-discovered gonorrhea targets. “We are thrilled about this partnership. It offers a unique opportunity to deliver our EDEN-identified antigens using mRNA and it accelerates clinical validation of the EDEN platform. This partnership has the potential to address a serious unmet global medical need […]
Biotech Business - October 6, 2020
Elicera Therapeutics has been launched and secures 13.2 MSEK
A new Swedish cell and gene therapy company, Elicera Therapeutics, has announced that it has completed its first share issue and secured 13.2 MSEK in financing. The company is based on research by professor Magnus Essand’s research group at Uppsala University and will focus on CAR T cells and oncolytic viruses. Four different drug candidates […]
Companies - June 5, 2015
AZ Pondering Future of Psoriasis Drug
AstraZeneca will need to decide soon whether to independently pursue an experimental psoriasis drug that has been linked to suicidal side effects, Bloomberg reported recently. “We want to take more time to look at the data and take time to engage with regulators,” AstraZeneca’s Chief Executive Officer Pascal Soriot told the news service about brodalumab. “We are actively contacting people who […]
Companies - June 4, 2015
Lundbeck Urges Alcohol Curbs
Danish drugmaker Lundbeck, which markets the alcoholism drug Selincro, last month mobilized members of the European Parliament, anti-alcohol NGOs and academics to convince the European Parliament to vote to urge the European Commission to take a harder position against the detrimental affects of alcohol. Lundbeck employees also quietly ran anti-alcohol campaigns behind the scenes, Politico […]
Companies - May 20, 2015
FDA Investigating Type 2 Diabetes Drugs
The U.S. Food and Drug Administration (FDA) is investigating diabetes drugs used to treat Type 2 diabetes made by Johnson & Johnson, AstraZeneca PLC and Eli Lilly and Company after 20 cases of ketoacidosis that required hospitalization were reported, according to BioSpace.com. Sodium-glucose cotransporter-2 (SGLT2) inhibitors used to treat type 2 diabetes may lead to […]
Companies - May 19, 2015
AstraZeneca to Build New Swedish Facility
AstraZeneca plans to spend $285 million to build a new drug manufacturing facility in Sodertalje, Sweden, so it can produce more drugs to be used in clinical trials, according to a BioSpace.com article. The plant is expected to bring 150 to 250 “highly skilled” new jobs to the area by 2019. The new facility is being designed […]
